205 related articles for article (PubMed ID: 32574685)
1. Ultrasound-responsive lipid microbubbles for drug delivery: A review of preparation techniques to optimise formulation size, stability and drug loading.
Al-Jawadi S; Thakur SS
Int J Pharm; 2020 Jul; 585():119559. PubMed ID: 32574685
[TBL] [Abstract][Full Text] [Related]
2. A versatile method for the preparation of particle-loaded microbubbles for multimodality imaging and targeted drug delivery.
Owen J; Crake C; Lee JY; Carugo D; Beguin E; Khrapitchev AA; Browning RJ; Sibson N; Stride E
Drug Deliv Transl Res; 2018 Apr; 8(2):342-356. PubMed ID: 28299722
[TBL] [Abstract][Full Text] [Related]
3. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
Tinkov S; Winter G; Coester C; Bekeredjian R
J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
[TBL] [Abstract][Full Text] [Related]
4. Comparing Strategies for Magnetic Functionalization of Microbubbles.
Beguin E; Bau L; Shrivastava S; Stride E
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1829-1840. PubMed ID: 30574777
[TBL] [Abstract][Full Text] [Related]
5. Effects of the microbubble shell physicochemical properties on ultrasound-mediated drug delivery to the brain.
Wu SY; Chen CC; Tung YS; Olumolade OO; Konofagou EE
J Control Release; 2015 Aug; 212():30-40. PubMed ID: 26065734
[TBL] [Abstract][Full Text] [Related]
6. Microbubble Formulations: Synthesis, Stability, Modeling and Biomedical Applications.
Upadhyay A; Dalvi SV
Ultrasound Med Biol; 2019 Feb; 45(2):301-343. PubMed ID: 30527395
[TBL] [Abstract][Full Text] [Related]
7. Characterization and Imaging of Lipid-Shelled Microbubbles for Ultrasound-Triggered Release of Xenon.
Shekhar H; Palaniappan A; Peng T; Lafond M; Moody MR; Haworth KJ; Huang S; McPherson DD; Holland CK
Neurotherapeutics; 2019 Jul; 16(3):878-890. PubMed ID: 31020629
[TBL] [Abstract][Full Text] [Related]
8. Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems.
Rudakovskaya PG; Barmin RA; Kuzmin PS; Fedotkina EP; Sencha AN; Gorin DA
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745808
[TBL] [Abstract][Full Text] [Related]
9. Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.
Dokania S; Joshi AK
Drug Deliv; 2015; 22(6):675-90. PubMed ID: 24670091
[TBL] [Abstract][Full Text] [Related]
10. Microbubbles as ultrasound triggered drug carriers.
Tinkov S; Bekeredjian R; Winter G; Coester C
J Pharm Sci; 2009 Jun; 98(6):1935-61. PubMed ID: 18979536
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical Characterization of the Shell Composition of PBCA-Based Polymeric Microbubbles.
Appold L; Shi Y; Rütten S; Kühne A; Pich A; Kiessling F; Lammers T
Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28371270
[TBL] [Abstract][Full Text] [Related]
12. Microbubbles as ultrasound contrast agents and in targeted drug delivery.
Sheffield P; Trehan A; Boyd B; Wong OL
Crit Rev Biomed Eng; 2008; 36(4):225-55. PubMed ID: 19961426
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the preparation of sonogenic phospholipids-based microbubbles by using central composite experimental design and response surface methodology.
Zhao YZ; Lu CT; Mei XG
Yao Xue Xue Bao; 2008 Aug; 43(8):862-7. PubMed ID: 18956781
[TBL] [Abstract][Full Text] [Related]
14. Engineering the Acoustic Response and Drug Loading Capacity of PBCA-Based Polymeric Microbubbles with Surfactants.
Barmin RA; Dasgupta A; Bastard C; De Laporte L; Rütten S; Weiler M; Kiessling F; Lammers T; Pallares RM
Mol Pharm; 2022 Sep; 19(9):3256-3266. PubMed ID: 35905480
[TBL] [Abstract][Full Text] [Related]
15. Polymeric microbubbles for ultrasonic molecular imaging and targeted therapeutics.
Xiong X; Zhao F; Shi M; Yang H; Liu Y
J Biomater Sci Polym Ed; 2011; 22(4-6):417-28. PubMed ID: 21144258
[TBL] [Abstract][Full Text] [Related]
16. [Development of Microbubbles for Theranostics and Its Application in Brain Targeted Drug Delivery].
Omata D
Yakugaku Zasshi; 2023; 143(10):785-790. PubMed ID: 37779005
[TBL] [Abstract][Full Text] [Related]
17. The acoustic signature of decaying resonant phospholipid microbubbles.
Thomas DH; Butler M; Pelekasis N; Anderson T; Stride E; Sboros V
Phys Med Biol; 2013 Feb; 58(3):589-99. PubMed ID: 23318409
[TBL] [Abstract][Full Text] [Related]
18. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
Pouton CW
Eur J Pharm Sci; 2000 Oct; 11 Suppl 2():S93-8. PubMed ID: 11033431
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound microbubble contrast agents: application to therapy for peripheral vascular disease.
Hu YZ; Zhu JA; Jiang YG; Hu B
Adv Ther; 2009 Apr; 26(4):425-34. PubMed ID: 19381521
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic applications of lipid-coated microbubbles.
Unger EC; Porter T; Culp W; Labell R; Matsunaga T; Zutshi R
Adv Drug Deliv Rev; 2004 May; 56(9):1291-314. PubMed ID: 15109770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
